IP Library Granted Patent US 10,774,106
Granted Patent B2
US 10,774,106 · App. 16/720,693 · Granted Sep 15, 2020

Uracyl spirooxetane nucleosides

Inventors: Ioannis Nicolaos Houpis (Antwerp, BE); Tim Hugo Maria Jonckers (Heist-op-den-Berg, BE); Pierre Jean-Marie Bernard Raboisson (Rosieres, BE); Abdellah Tahri (Anderlecht, BE)
Assignee: Janssen Sciences Ireland Unlimited Company
C07H19/10A61K31/7072C07H1/00C07H19/06C07H19/11C07H19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,774,106
App. No.
16/720,693
Granted
Sep 15, 2020
Kind
B2
Abstract

The present invention relates to compounds of the formula I: including any possible stereoisomers thereof, wherein R 9 has the meaning as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.

Claims (17)

1. A compound of formula Ib:

2. A pharmaceutical composition comprising a compound according to claim 1 , and a pharmaceutically acceptable carrier.

3. A method of preparing a compound of formula (7),

comprising

reacting a compound of formula (12) with POCl 3 to provide a compound of formula (6);

reacting a compound of formula (6) with a compound of formula (4),

wherein R 9 is selected from the group consisting of C 1 -C 6 alkyl, phenyl, naphtyl, C 3 -C 7 cycloalkyl, and Y, wherein Y is C 1 -C 3 alkyl substituted with 1, 2 or 3

substituents each independently selected from the group consisting of phenyl, C 3 -C 6 cycloalkyl, hydroxy and C 1 -C 6 alkoxy.

4. A method as claimed in claim 3 , wherein said reacting a compound of formula (6) with a compound of formula (4) takes place in the presence of triethylamine.

5. A method as claimed in claim 3 , wherein said reacting a compound of formula (6) with a compound of formula (4) takes place in the presence of N-methylimidazole.

6. A method as claimed in claim 3 , wherein said reacting a compound of formula (6) with a compound of formula (4) takes place in dichloromethane.

7. A method as claimed in claim 3 , wherein said reacting a compound of formula (6) with a compound of formula (4) takes place in the presence of triethylamine and N-methylimidazole in dichloromethane.

8. A method as claimed in claim 3 , wherein R 9 is C 1 -C 6 alkyl.

9. A method as claimed in claim 3 , wherein R 9 is C 3 -C 7 cycloalkyl.

10. A method as claimed in claim 3 , wherein R 9 is isopropyl.

11. A method as claimed in claim 3 , wherein R 9 is C 2 -C 4 alkyl.

12. A method as claimed in claim 3 , wherein R 9 is C 1 -C 2 alkyl substituted with phenyl.